Actively Recruiting
Tubeless VATS for Mediastinal Neoplasm
Led by Shuben Li · Updated on 2025-07-15
132
Participants Needed
1
Research Sites
179 weeks
Total Duration
On this page
Sponsors
S
Shuben Li
Lead Sponsor
T
The First Affiliated Hospital of Guangzhou Medical University
Collaborating Sponsor
AI-Summary
What this Trial Is About
In recent year, non-intubated anesthesia had emerged as an available and promising alternative for thoracic procedure. However, its safety and feasibility in video-assisted thoracoscopic surgery (VATS) for mediastinal neoplasm remain controversial. This randomized controlled trial is designed to evaluate the impact of the non-intubated approach on surgical and perioperative outcomes in patients undergoing mediastinal neoplasm resection.
CONDITIONS
Official Title
Tubeless VATS for Mediastinal Neoplasm
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Mediastinal neoplasm diagnosed by chest enhanced CT
- Age between 18 and 80 years old
- Tumor diameter less than 6 cm
- ASA grade I to III
- Ability to understand the research and provide informed consent
You will not qualify if you...
- Tumor invading adjacent organs or evidence of pleural/pericardial spread or metastases
- History of congestive heart failure, poorly controlled angina, recent myocardial infarction, uncontrolled hypertension, significant valvular heart disease, or unmanaged high-risk arrhythmias
- Presence of other active malignancies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510120
Actively Recruiting
Research Team
S
Shuben Li, Deputy Director
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here